AB — AB Science SA Share Price
Last Trade - 00:00- €643.64m
- €642.88m
- €1.58m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 1.51 | 1.74 | 1.7 | 1.57 | 1.58 | 1.6 | 2 | -7.07% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
AB Science SA, also known as AB Science, is a France-based pharmaceutical company specialized in the research, discovery, development and marketing of protein kinase inhibitors (PKIs). It is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine. The main focus of the Company is the development of tyrosine kinase inhibitors, for instance Masitinib which is a tyrosine kinase inhibitor used as a veterinary medicine in the treatment of canine mast cell tumors. The Company is present in the United States and Europe. As of December 31, 2013, the Company operated though a subsidiary, AB Science USA LCC, based in the United States.
Directors
- Alain Moussy
- Denis Gicquel
- Laurent Guy
- Jean-Pierre Kinet
- Patrick Moussy
- Beatrice Bihr
- Emmanuelle Mourey
- Nathalie Riez Thiollet
- Last Annual
- December 31st, 2020
- Last Interim
- December 31st, 2020
- Incorporated
- July 3rd, 2001
- Public Since
- April 21st, 2010
- No. of Employees
- 92
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 52,456,357
- Address
- 3 avenue George V, PARIS, 75008
- Web
- http://www.ab-science.com/
- Phone
- +33 147200014
- Auditors
- KPMG AUDIT
Latest News for AB
Upcoming events for AB
Ab Science SA Annual Shareholders Meeting
Similar to AB
DBV TECHNOLOGIES ORD
Euronext - Paris
NICOX ORD
Euronext - Paris
FAQ
As of Today at 19:56 UTC, shares in AB Science SA are trading at €12.27. This share price information is delayed by 15 minutes.
Shares in AB Science SA last closed at €12.27 and the price had moved by +43.34% over the past 365 days. In terms of relative price strength the AB Science SA share price has outperformed the FTSE Global All Cap Index by +11.3% over the past year.
The overall consensus recommendation for AB Science SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
AB Science SA does not currently pay a dividend.
AB Science SA does not currently pay a dividend.
AB Science SA does not currently pay a dividend.
To buy shares in AB Science SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €12.27, shares in AB Science SA had a market capitalisation of €643.64m.
Here are the trading details for AB Science SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: AB
Based on an overall assessment of its quality, value and momentum AB Science SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in AB Science SA is €10.00. That is 18.5% below the last closing price of €12.27.
Analysts covering AB Science SA currently have a consensus Earnings Per Share (EPS) forecast of -€0.32 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AB Science SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -29.71%.
As of the last closing price of €12.27, shares in AB Science SA were trading -9.53% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for AB Science SA.
AB Science SA's management team is headed by:
- Alain Moussy -
- Denis Gicquel -
- Laurent Guy -
- Jean-Pierre Kinet -
- Patrick Moussy -
- Beatrice Bihr -
- Emmanuelle Mourey -
- Nathalie Riez Thiollet -
We do not have data on AB Science SA's shareholders